Liangan Chen
-
- Lung Cancer Diagnosis and Treatment 23
- Lung Cancer Treatments and Mutations 20
- Respiratory Support and Mechanisms 13
- Neonatal Respiratory Health Research 11
- Chronic Obstructive Pulmonary Disease (COPD) Research 11
- Tracheal and airway disorders 10
- Cancer Research top 5%
- Genetics top 5%
-
- RNA modifications and cancer 11
-
- Antibiotic Resistance in Bacteria 10
- Co-authors
- Zhixin LiangZhen YangQing TianChunsun LiJie ChenYu DaiShile HuangJun Chung
- Journals
- Frontiers in Oncology (4 papers)Antimicrobial Resistance and Infection Control (3 papers)PLoS ONE (3 papers)
- Partner nations
- ChinaPhilippinesUnited States
In The Last Decade
Liangan Chen
129 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 136
- Pulmonary and Respiratory Medicine 955
- Cancer Research 395
- Genetics 194
- Applied Microbiology and Biotechnology 35
- Critical Care and Intensive Care Medicine 79
Countries citing papers authored by Liangan Chen
This map shows the geographic impact of Liangan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liangan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liangan Chen more than expected).
Fields of papers citing papers by Liangan Chen
This network shows the impact of papers produced by Liangan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liangan Chen. The network helps show where Liangan Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Liangan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 7 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 23 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 6 | |
| 8 | 2021 | 29 | |
| 9 | Circ_0058124 Upregulates MAPK1 Expression to Promote Proliferation, Metastasis and Metabolic Abilities in Thyroid Cancer Through Sponging miR-940 | 2020 | 1 |
| 10 | 2018 | 68 | |
| 11 | 2017 | 27 | |
| 12 | 2015 | 45 | |
| 13 | 2015 | 50 | |
| 14 | 2014 | 31 | |
| 15 | 2013 | 0 | |
| 16 | 2013 | 16 | |
| 17 | 2013 | 54 | |
| 18 | Application of EBUS-TBNA and PET/CT in diagnosing enlarged mediastinal lymph nodes caused by unknown reasons | 2012 | 1 |
| 19 | Blastomycosis in China: a case report and literature review. | 2011 | 11 |
| 20 | [Dynamic changes of immunoglobulin G in convalescents who have suffered from severe acute respiratory syndrome patients]. | 2004 | 1 |
About Liangan Chen
Liangan Chen is a scholar working on Pulmonary and Respiratory Medicine, Molecular Medicine, Microbiology, Anesthesiology and Pain Medicine and Cancer Research, having authored 138 papers that have together received 2.5k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (23 papers), Lung Cancer Treatments and Mutations (20 papers), Respiratory Support and Mechanisms (13 papers), Neonatal Respiratory Health Research (11 papers), RNA modifications and cancer (11 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers), Antibiotic Resistance in Bacteria (10 papers) and Tracheal and airway disorders (10 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (955 citations), Cancer Research (395 citations), Genetics (194 citations), Applied Microbiology and Biotechnology (35 citations) and Critical Care and Intensive Care Medicine (79 citations). Liangan Chen has collaborated with scholars based in China, Philippines and United States. Frequent co-authors include Zhixin Liang, Zhen Yang, Qing Tian, Chunsun Li, Jie Chen, Yu Dai, Shile Huang, Jun Chung, Chonghui Li and Yanwen Jiang. Their work appears in journals such as Frontiers in Oncology, Antimicrobial Resistance and Infection Control, PLoS ONE, Annals of Palliative Medicine and Respiratory Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.